atai Life Sciences (NASDAQ:ATAI, ETR:9VC) told investors it will be participating in the H.C. Wainwright 5th Annual Neuro Perspectives Conference taking place on Thursday, June 27, 2024.
The company will be participating in a virtual fireside chat at 7am Eastern Time and one-on-one investor meetings. The fireside chat can be accessed here.
atai is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders and was founded as a response to the significant unmet need and lack of innovation in the mental health treatment landscape.